Skip to main content
OpenTrials
Completed

NCT Number: NCT02675361

Effectiveness of a Transition Program for Adolescents With Congenital Heart Disease in the Transition to Adulthood

This study is part of a larger research project known as Swedish Transition Effects Project Supporting Teenagers with chrONic mEdical conditionS (STEPSTONES). This project was created to develop and evaluate transition programs in order to support adolescents with chronic conditions in Sweden. While STEPSTONES has a generic nature, the first transition program that will be evaluated targets adolescents with congenital heart disease (ConHD).

This particular study involves a hybrid experimental design, meaning a randomized controlled trial is embedded in a longitudinal, observational study. This type of design will help to test the effectiveness of a transition program in order to empower adolescents with congenital heart disease in the transition to adulthood and check for potential contamination of the comparison group. We will recruit 210 participants: 140 adolescents will be part of the randomized controlled trial (70 in the intervention arm; 70 in the comparison arm), and 70 participants will be assigned to the observational, longitudinal arm of the study, which serves as control group in an intervention-naive center. Over a period of two years, three assessments will be done during which all participants will be asked to answer a set of questionnaires.

The intervention to be tested involves patient empowerment, education on their ConHD, dealing with school, health behaviors required to maintain good health, guidance of parents, a person-centered transition plan, among others. The study hypothesis is that adolescents with ConHD who received a structured, person-centered transition program over a 2-year period have a higher patient empowerment score than adolescents who receive usual care.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year–16 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Heart Center, Queen Silvia Children and Youth Hospital, Gothenburg, Sweden

Loading trial locations.

About this study

Congenital heart diseases (ConHD) represent 28% of all congenital abnormalities.This population has experienced an increased life expectancy due to improvements in medical services and surgical techniques. Currently, around 90% of them will reach adulthood. Due to the complexity of these disorders, children with ConHD have to be under continuing follow-up. However, when they reach 18 years, they will be transferred to adult care. In order to help the adolescent in the transitions to adulthood and adult care, transitions programs have been proposed as a complex intervention with the objective of maximizing lifelong functioning and potential through appropriate healthcare services.

Patient empowerment is recognized as an essential element of transition interventions.Through the promotion of patient empowerment the adolescents can become active partners in their care and have the knowledge and capacity to make decisions that affect their life and health status.

While the importance of transition programs has been mentioned previously, high level evidence on the effectiveness of these interventions is limited. The purpose of this study is to assess the effectiveness of a transition program for adolescents with congenital heart disease. In order to asses the effectiveness of the transition program the investigators proposed a hybrid experimental design where a randomized controlled trial is embedded in a longitudinal, observational study.

During the course of the study, participants will be part of a transition program or receive usual care before being transferred to adult care. The primary outcome is level of empowerment and secondary outcomes include patient-reported health, illness perception, quality of life, health behaviors, knowledge on congenital heart disease, transition readiness, parental uncertainty and parenting.

The investigators will assess the effectiveness of the transition program by comparing the level of empowerment between the participants who received usual care and those who participated in the transition program. A higher level of empowerment from the group part of the intervention it's expected.

A process and economic evaluation of the intervention will also be undertaken. The process evaluation will evaluate the process of care delivery within the transition program. This information will helped describe the mechanism of impact, explore potential expansion to other chronic conditions and to prepare permanent implementation of the transition program in Sweden.

The economic evaluation entails an impact budget assessment and a cost-effectiveness analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Literate
  • Swedish-speaking
  • Diagnosed with a congenital heart disease
  • Age: 16 years

Exclusion criteria

  • Syndromes affecting cognitive abilities
  • Acquired heart diseases
  • Heart transplantation

Treatment and study plan

Transition program

Behavioral

Participants will be part of a transition program with eight key components: 1. A transition coordinator; 2. Education on congenital heart disease (CHD), treatments, health behavior, dealing with school, friends; 3. Telephone availability; 4. Information about the Grown-Up Congenital Heart Disease (GUCH) program: 5. Guidance of parents; 6. Meeting with peers: 7. A person-centered transition plan; and 8. Transfer to Grown-Up Congenital Heart Disease clinic. The intervention will be implemented by specialized nurses at the outpatient clinic of pediatric cardiology. Overall, 60 to 90 minutes per patient are spent over the 2.5 years.

Primary outcomes

  1. Level of empowerment

    Time frame: Three measurements over a 2-year period.

    Gothenburg Young Persons Empowerment Scale (GYPES) will be used to assess the level of empowerment. This scale was developed by the researchers involved in this study and has been tested in a previous cross sectional study in order to determine its psychometric properties in adolescents with congenital heart disease. The investigators will compare the level of empowerment between groups before and after the transfer of care. Empowerment level will be measured at three different points, when the participants are 16 (baseline), 17 (midterm) and 18 years old (after transfer).

Secondary outcomes

  1. Transition readiness

    Time frame: Three measurements over a 2-year period.

    Readiness for transition questionnaire (adolescent version)

  2. Knowledge

    Time frame: Three measurements over a 2-year period.

    Knowledge scale for adults with congenital malformed hearts

  3. Health behavior

    Time frame: Three measurements over a 2-year period.

    Health behavior scale-congenital heart disease

  4. Patient reported health I

    Time frame: Three measurements over a 2-year period.

    Questionnaire (PedsQL 4.0) (generic and cardiac module)

  5. Quality of life

    Time frame: Three measurements over a 2-year period.

    Linear analog scale

  6. Patient reported health II

    Time frame: Three measurements over a 2-year period.

    Questionnaire (EQ-5D-3L)

  7. Healthcare utilization

    Time frame: Three measurements over a 2-year period.

    Healthcare utilization questionnaire

Sponsors and collaborators

Lead sponsor

Göteborg University

Other

Collaborators

  • Karolinska University Hospital
  • Norrlands University Hospital
  • Sahlgrenska University Hospital
  • Skane University Hospital
  • Swedish Children Heart Association
  • Swedish Council for Working Life and Social Research
  • Swedish Heart Lung Foundation
  • The Swedish Research Council

Registry information

Official study title

Effectiveness of a Transition Program to Empower Adolescents With Congenital Heart Disease in the Transition to Adulthood: the STEPSTONES Project

Important dates

Study start
2016
Primary completion
2021
Study completion
2021
First posted
Feb 5, 2016
Registry last updated
Jul 2, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.